Cerenome (PSTV) Intangibles (2010 - 2026)
Plus Therapeutics (PSTV) posted quarterly Intangibles of $299000.0 for Q1 2026, down 31.26% year-over-year from $435000.0 in Q1 2025, and down 10.21% quarter-over-quarter from $333000.0 in Q4 2025.
Cerenome (PSTV) Intangibles (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has reported Intangibles for 17 consecutive years, with $299000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Intangibles fell 31.26% year-over-year to $299000.0; the TTM figure through Mar 2026 stood at $299000.0 (down 31.26% YoY), while the FY2025 annual figure was $333000.0, down 29.0% from the prior year.
- Intangibles declined to $299000.0 in Q1 2026 per PSTV's latest filing, from $333000.0 in the prior quarter.
- Across five years, Intangibles topped out at $557000.0 in Q2 2024 and bottomed at $33000.0 in Q1 2024.
- Historically, Intangibles has averaged $243294.1 across 5 years, with a median of $150000.0 in 2022.
- Annual changes were most pronounced in 2024 — Intangibles plunged 58.23% — and 2025, when it jumped 1218.18%.
- Plus Therapeutics' Intangibles stood at $94000.0 in 2022, then tumbled by 55.32% to $42000.0 in 2023, then jumped by 1016.67% to $469000.0 in 2024, then fell by 29.0% to $333000.0 in 2025, then fell by 10.21% to $299000.0 in 2026.
- Business Quant data shows PSTV's Intangibles at $299000.0 in Q1 2026, $333000.0 in Q4 2025, and $374000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | 265,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 299,000.00 |
| Dec 31, 2025 | 333,000.00 |
| Sep 30, 2025 | 374,000.00 |
| Jun 30, 2025 | 401,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | 469,000.00 |
| Sep 30, 2024 | 513,000.00 |
| Jun 30, 2024 | 557,000.00 |
| Mar 31, 2024 | 33,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Mar 31, 2023 | 79,000.00 |
| Dec 31, 2022 | 94,000.00 |
| Sep 30, 2022 | 113,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Mar 31, 2022 | 150,000.00 |
| Dec 31, 2021 | 51,000.00 |
| Sep 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 69,000.00 |